Anaplastic B-cell (Ki-1) lymphoma developing in a patient with polycythemia vera

Leukemia & Lymphoma
E SteinbergG Lugassy

Abstract

The association of lymphoproliferative disorders and polycythemia vera (PV) is extremely rare. Here we report a patient with PV who developed anaplastic B-cell (Ki-1) non-Hodgkin's lymphoma (NHL). The rare occurrence of lymphoproliferative disorder in the course of PV, may indicate that in a minority of patients, clonal expansion of an abnormal pluripotent haemopoetic stem cell could be responsible for both the PV and the NHL.

References

Jul 1, 1978·Annals of Internal Medicine·R HoffmanR P McCaffrey
May 1, 1979·Cancer·H W HannE Cifuentes
Feb 1, 1986·The American Journal of Medicine·T A BraichB R Greenberg
Jan 1, 1987·Clinical and Laboratory Haematology·R AitchisonM F Greaves
Jun 1, 1971·Cancer·N J Vianna, L J Essman
Oct 1, 1966·Archives of Internal Medicine·E W HeinleM P Westerman
May 1, 1994·Journal of Clinical Pathology·J R NeilsonB J Boughton
Jul 1, 1993·Journal of Clinical Pathology·J M HernándezJ F San Miguel
Aug 1, 1949·The American Journal of the Medical Sciences·J H LAWRENCE, R L ROSENTHAL

❮ Previous
Next ❯

Citations

Apr 12, 2003·Seminars in Hematology·Harriet S Gilbert
Feb 26, 1999·Leukemia & Lymphoma·M CamósE Montserrat
Oct 8, 1999·Leukemia & Lymphoma·C WickenhauserK Scharffetter-Kochanek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.